Menu
Back to Journals » OncoTargets and Therapy
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6337)
- Volume 16, 2023 (46)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Journal Articles:
- 6,337 records -
JUND Promotes Tumorigenesis via Specifically Binding on Enhancers of Multiple Oncogenes in Cervical Cancer
Zhou J, Mo J, Tan C, Xie F, Liang J, Huang W
OncoTargets and Therapy 2023, 16:347-357
Published Date: 31 May 2023
High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma
Ma K, Guo Q, Zhang X, Li Y
OncoTargets and Therapy 2023, 16:331-345
Published Date: 29 May 2023
LINC00958 Promotes the Malignancy of Nasopharyngeal Carcinoma by Sponging microRNA-625 and Thus Upregulating NUAK1 [Retraction]
Chen M, Xu Z, Zhang Y, Zhang X
OncoTargets and Therapy 2023, 16:329-330
Published Date: 26 May 2023
Circ_0005576 Promotes Malignant Progression Through miR-874/CDK8 Axis in Colorectal Cancer [Retraction]
Yu C, Li S, Hu X
OncoTargets and Therapy 2023, 16:327-328
Published Date: 18 May 2023
The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib
Chen KC, Huang YH, Hsu KH, Tseng JS, Chang GC, Yang TY
OncoTargets and Therapy 2023, 16:317-326
Published Date: 17 May 2023
KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a [Retraction]
Zhang Q, Xu L, Wang J, Zhu X, Ma Z, Yang J, Li J, Jia X, Wei L
OncoTargets and Therapy 2023, 16:315-316
Published Date: 15 May 2023
LINC00565 Enhances Proliferative Ability in Endometrial Carcinoma by Downregulating KLF9 [Retraction]
Yin X, Li X, Feng G, Qu Y, Wang H
OncoTargets and Therapy 2023, 16:313-314
Published Date: 15 May 2023
MicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction]
Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W
OncoTargets and Therapy 2023, 16:311-312
Published Date: 11 May 2023
KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction]
Yang GH, Ren ZX, Yang X, Zhang YG
OncoTargets and Therapy 2023, 16:309-310
Published Date: 9 May 2023
Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin
Wijnen NE, Koedijk JB, Klein K, Luesink M, Goemans BF, Zwaan CM, Kaspers GJL
OncoTargets and Therapy 2023, 16:297-308
Published Date: 29 April 2023
MNK Proteins as Therapeutic Targets in Leukemia
Mazewski C, Platanias LC
OncoTargets and Therapy 2023, 16:283-295
Published Date: 21 April 2023
LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]
Song X, Xu X, Ren X, Ruan X, Wang Y, Yao TT
OncoTargets and Therapy 2023, 16:281-282
Published Date: 21 April 2023
Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers [Corrigendum]
Ma DN, Gao XY, Dan YB, Zhang AN, Wang WJ, Yang G, Zhu HZ
OncoTargets and Therapy 2023, 16:279-280
Published Date: 20 April 2023
Resveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial–Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells [Retraction]
Sun H, Zhang Z, Zhang T, Geng H, Xie D, Wang Y, Ding D, Zhang T, Yu D
OncoTargets and Therapy 2023, 16:277-278
Published Date: 18 April 2023
Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction]
Tan T, Chen J, Hu Y, Wang N, Chen Y, Yu T, Lin D, Yang S, Luo J, Luo X
OncoTargets and Therapy 2023, 16:275-276
Published Date: 12 April 2023
Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma
Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T, Ohsawa M, Hirohata R, Kitasaki N, Okada M
OncoTargets and Therapy 2023, 16:263-273
Published Date: 10 April 2023
miR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction]
Cao J, Li L, Han X, Cheng H, Chen W, Qi K, Chen C, Wu Q, Niu M, Zeng L, Xu K
OncoTargets and Therapy 2023, 16:261-262
Published Date: 8 April 2023
Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions
O'Sullivan HM, Feber A, Popat S
OncoTargets and Therapy 2023, 16:249-259
Published Date: 7 April 2023
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
Stella S, Martorana F, Massimino M, Vitale SR, Manzella L, Vigneri P
OncoTargets and Therapy 2023, 16:235-247
Published Date: 7 April 2023
MicroRNA-143-3p Suppresses Tumorigenesis by Targeting Catenin-δ1 in Colorectal Cancer [Retraction]
Ding X, Du J, Mao K, Wang X, Ding Y, Wang F
OncoTargets and Therapy 2023, 16:233-234
Published Date: 6 April 2023
From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma
Simonetti E, Cutarella S, Valente M, Sani T, Ravara M, Maio M, Di Giacomo AM
OncoTargets and Therapy 2023, 16:227-232
Published Date: 5 April 2023
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
Badiginchala R, Dattatreya PS, Suresh AVS, Nirni SS, Andra VV, Bunger D, Chaturvedi A
OncoTargets and Therapy 2023, 16:215-225
Published Date: 1 April 2023
Matrine Suppresses the Migration and Invasion of NSCLC Cells by Inhibiting PAX2-Induced Epithelial-Mesenchymal Transition [Retraction]
Yang J, He D, Peng Y, Zhong HZ, Deng YH, Yu Z, Guan C, Zuo Y, Xu Z
OncoTargets and Therapy 2023, 16:213-214
Published Date: 29 March 2023
CXCL8 Promotes Glioma Progression by Activating the JAK/STAT1/HIF-1α/Snail Signaling Axis [Retraction]
Chen Z, Mou L, Pan Y, Feng C, Zhang J, Li J
OncoTargets and Therapy 2023, 16:211-212
Published Date: 28 March 2023
Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel
Hu J, He Q, Tian T, Chang N, Qian L
OncoTargets and Therapy 2023, 16:197-210
Published Date: 27 March 2023
Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date
Varella L, Cristofanilli M
OncoTargets and Therapy 2023, 16:189-196
Published Date: 23 March 2023
Role of Systemic Immunoinflammation Landscape in the Overall Survival of Patients with Leptomeningeal Metastases from Lung Cancer
Wang JW, Yuan Q, Li L, Cao KH, Liu Q, Wang HL, Hu K, Wu X, Wan JH
OncoTargets and Therapy 2023, 16:179-187
Published Date: 23 March 2023
Portulacerebroside a Inhibits Adhesion, Migration, and Invasion of Human Leukemia HL60 Cells and U937 Cells through the Regulation of p38/JNK Signaling Pathway [Retraction]
Ye QD, Liao XL, Fu P, Dou JY, Chen K, Jiang H
OncoTargets and Therapy 2023, 16:177-178
Published Date: 16 March 2023
A Review of CAR-T Therapy in Pediatric and Young Adult B-Lineage Acute Leukemia: Clinical Perspectives in Singapore
Seng MS, Meierhofer AC, Lim FL, Soh SY, Hwang WYK
OncoTargets and Therapy 2023, 16:165-176
Published Date: 14 March 2023
Clinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study
Li G, Cheng M, Hong K, Jiang Y
OncoTargets and Therapy 2023, 16:157-163
Published Date: 6 March 2023
Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article)
El Sayed SM
OncoTargets and Therapy 2023, 16:143-155
Published Date: 5 March 2023
Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect [Corrigendum]
Yan X, Liu SM, Liu C
OncoTargets and Therapy 2023, 16:141-142
Published Date: 1 March 2023
Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report
Alanzi M, Abu-Tineh M, Szabados L, Sharaf Eldean M, Alatasi S, Taha RY, Elkourashy SA
OncoTargets and Therapy 2023, 16:133-139
Published Date: 21 February 2023
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks
Mandó P, Waisberg F, Pasquinelli R, Rivero S, Ostinelli A, Perazzo F
OncoTargets and Therapy 2023, 16:115-132
Published Date: 19 February 2023
Ineffectiveness of Crizotinib in a Non-Small-Cell Lung Cancer with Novel ALK- LIMS1 Fusion: A Case Report
Shi J, Jia Z, Zhou Z, Zhao L, Meng Q, Liu Y
OncoTargets and Therapy 2023, 16:109-114
Published Date: 17 February 2023
Neoadjuvant PD-1 Blockade in Non-Small Cell Lung Cancer: Current perspectives and Moving Forward
Shinada K, Murakami S
OncoTargets and Therapy 2023, 16:99-108
Published Date: 15 February 2023
Secondary Sinonasal Collision Tumor of Papillary Squamous Cell Carcinoma and Small Cell Neuroendocrine Carcinoma After Nasopharyngeal Carcinoma Radiotherapy: A Case Report and Literature Review of Sinonasal Collision Carcinomas
Tang H, Wang L, Xu W, Xu Y, Li X, Guo D
OncoTargets and Therapy 2023, 16:91-97
Published Date: 11 February 2023
Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
Zhang X, Ni K, Chen H
OncoTargets and Therapy 2023, 16:87-90
Published Date: 25 January 2023
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
Pineda E, Domenech M, Hernández A, Comas S, Balaña C
OncoTargets and Therapy 2023, 16:71-86
Published Date: 25 January 2023
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report
Misawa K, Nakamichi S, Iida H, Nagano A, Mikami E, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Kubota K, Yamaguchi H, Seike M
OncoTargets and Therapy 2023, 16:65-69
Published Date: 24 January 2023
Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction
Buller DM, Antony M, Ristau BT
OncoTargets and Therapy 2023, 16:49-64
Published Date: 24 January 2023
miR-497 Inhibited Proliferation, Migration and Invasion of Thyroid Papillary Carcinoma Cells by Negatively Regulating YAP1 Expression [Retraction]
Cheng H, Dong H, Feng J, Tian H, Zhang H, Xu L
OncoTargets and Therapy 2023, 16:47-48
Published Date: 19 January 2023
FMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile
Garciaz S, Hospital MA
OncoTargets and Therapy 2023, 16:31-45
Published Date: 19 January 2023
A Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib
Fan W, Wang C, Zhong X, Zheng Y, Chen T, Huang M, Su S
OncoTargets and Therapy 2023, 16:23-29
Published Date: 19 January 2023
A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review
Li D, Liu X, Cui S, Yang D, Zhu Y, Pan E, Yang P, Dai Z
OncoTargets and Therapy 2023, 16:17-22
Published Date: 18 January 2023
Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
Varadarajan I, Pierce E, Scheuing L, Morris A, El Chaer F, Keng M
OncoTargets and Therapy 2023, 16:1-16
Published Date: 14 January 2023
Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival
Cerón R, Martínez A, Ramos C, De la Cruz A, García A, Mendoza I, Palmeros G, Montaño Figueroa EH, Navarrete J, Jiménez-Morales S, Martinez-Murillo C, Olarte I
OncoTargets and Therapy 2022, 15:1583-1595
Published Date: 30 December 2022
Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer
Ho MC, Chung YS, Lin YC, Hung MS, Fang YH
OncoTargets and Therapy 2022, 15:1573-1582
Published Date: 28 December 2022
Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides difficile Infection Among Patients with Lung Cancer
Chung YS, Lin YC, Hung MS, Ho MC, Fang YH
OncoTargets and Therapy 2022, 15:1563-1571
Published Date: 28 December 2022
Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes
Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F
OncoTargets and Therapy 2022, 15:1545-1561
Published Date: 22 December 2022